Back
Bolsa Mexicana de Valores SAB de CV Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
52
BOMXF
Bolsa Mexicana de Valores SAB de CV
Last Price:
$2.13
Seasonality Move:
-10.96%
Buy
68
SRPT
Sarepta Therapeutics
Last Price:
$63.65
Seasonality Move:
16.21%
Buy
52
Bolsa Mexicana de Valores SAB de CV (BOMXF)
is a Buy
Is Bolsa Mexicana de Valores SAB de CV a Buy, Sell or Hold?
-
The current Bolsa Mexicana de Valores SAB de CV [BOMXF] share price is $2.11. The Score for BOMXF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BOMXF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $63.51. The Score for SRPT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BOMXF Stock Price Chart
What is Bolsa Mexicana de Valores SAB de CV's stock price today?
-
The Bolsa Mexicana de Valores SAB de CV share price today is $2.11Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BOMXF is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $63.51The current trend is relatively stagnant and SRPT is experiencing slight selling pressure.
BOMXF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 65.13 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.74 - 2.04) | Buy |
Bollinger Bands (100): | (1.58 - 1.9) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.05 | Sell |
Relative Strength Index (14 RSI): | 49.01 | Sell |
Chaikin Money Flow: | -325446 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.12 - 63.24) | Buy |
Bollinger Bands (100): | (71.35 - 124.31) | Sell |
BOMXF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.05 | Buy |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 1.87 | Buy |
200-day SMA: | 1.68 | Buy |
8-day EMA: | 2.05 | Buy |
20-day EMA: | 1.97 | Buy |
50-day EMA: | 1.87 | Buy |
200-day EMA: | 1.76 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.59 | Buy |
20-day SMA: | 56.86 | Buy |
50-day SMA: | 76.27 | Sell |
200-day SMA: | 113.9 | Sell |
8-day EMA: | 61.31 | Buy |
20-day EMA: | 61.63 | Buy |
50-day EMA: | 73.93 | Sell |
200-day EMA: | 103.71 | Sell |
Bolsa Mexicana de Valores SAB de CV Earnings Growth & BOMXF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.
Bolsa Mexicana de Valores SAB de CV Technical Analysis
Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |